Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

30 results about "Sprivivirus" patented technology

Sprivivirus is a genus of viruses in the family Rhabdoviridae, order Mononegavirales. Fish serve as natural hosts.

Antisense antiviral compound and method for treating ssRNA viral infection

The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Flaviviridae, Picomoviridae, Caliciviridae, Togaviridae, Arteriviridae, Coronaviridae, Astroviridae and Hepeviridae families in the treatment of a viral infection. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides having a sequence of 1240 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with stem-loop secondary structure within the 5′-terminal end 40 bases of the positive-sense RNA strand of the virus.
Owner:AVI BIOPHARMA

Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav

The present invention relates nucleic acid constructs for the production of recombinant parvoviral (e.g. adeno-associated viral) vectors in insect cells, to insect cells comprising such constructs and to methods wherein the cells are used to produce recombinant parvoviral virions. The insect cells preferably comprise a first nucleotide sequence encoding the parvoviral rep proteins whereby the initiation codon for translation of the parvoviral Rep78 protein is a suboptimal initiation codon that effects partial exon skipping upon expression in insect cells. The insect cell further comprises a second nucleotide sequence comprising at least one parvoviral (AAV) inverted terminal repeat (ITR) nucleotide sequence and a third nucleotide sequence comprising a sequences coding for the parvoviral capsid proteins.
Owner:UNIQURE IP BV

Methods for real-time multiplex isothermal detection and identification of bacterial, viral, and protozoan nucleic acids

Herein disclosed are rapid real-time isothermal multiplex methods of detecting, identifying and quantifying bacterial, viral, and protozoan nucleic acids in a sample. These include contacting the sample with two or more sets of pathogen-specific reverse transcription loop-mediated isothermal amplification primers and novel oligofluorophores specific for the target bacterial, viral, and parasitic nucleic acids of interest such as human immunodeficiency virus, Ebola virus, Marburg virus, Yellow fever virus, hepatitis-B virus, Lassa fever virus, Plasmodium, hepatitis-C virus, hepatitis-E virus, dengue virus, Chikungunya virus, Japanese Encephalitis virus, Middle Eastern Respiratory Syndrome Corona virus, Mycobacterium, West Nile virus, Cytomegalovirus, Parvovirus, Leishmania, Trypanosoma, and Zika virus nucleic acids, under conditions sufficient to produce detectable real-time amplification signals in about 10 to 40 minutes. The amplification signals are produced by pathogen-specific fluorogenic labels included in one or more of the primers. Also, novel reaction and sample lysis buffers, primers, and kits for rapid multiplex detection, quantification, and identification of bacterial, viral, and protozoan nucleic acids by real-time isothermal amplification are herein disclosed.
Owner:NYAN DOUGBEH CHRIS

Multiple real-time quantitative PCR primer, probe and detection method for identifying viral pathogens relevant to fever with eruption syndrome as infection diseases

The invention discloses multiple real-time quantitative PCR primer, probe and a detection method for identifying viral pathogens relevant to fevers with eruption syndromes as infection diseases, which is used for carrying out multiple real-time fluorescent quantitative PCR detection on varicella-herpes zoster viruses, human small DNA (Deoxyribonucleic Acid) viruses B19, enteroviruses (enteroviruses 71 type and coxsackie viruses A16 type), dengue viruses, rubella viruses and measles viruses. The invention can simultaneously carry out qualitative or quantitative detection on eight kinds of human viruses in various types of samples by multiple double-tubes PCR. The detection method has the advantages of simple operation, short time consumption, high sensitivity and strong specificity, is suitable for field detection, early diagnosis, epidemics detection and research and the like, and takes the actions of assistance and identification diagnosis on the fevers with eruption syndromes.
Owner:SUN YAT SEN UNIV

Fluorescent quantitative primer group for visual differential diagnosis of waterfowl parvoviruses

The invention discloses a real-time fluorescent quantitative PCR (Polymerase Chain Reaction) primer group for visual detection on infection conditions of goose parvovirus (GPV) and muscovy duck parvovirus (MDPV) and a method thereof. According to the method, the detection on the infection conditions of GPV and MDPV is carried out by using dissolution curve temperature difference caused by the difference between nucleotide GC contents of GPV and MDPV specific gene fragment regions amplified by primers, and the infection conditions of GPV and MDPV can be subjected to visual differential diagnosis specifically by only combining the SYBR Green I based real-time fluorescent quantitative PCR primer group to dissolution curves which are automatically generated after reaction is ended. The method disclosed by the invention is simple and is relatively high in efficiency and accuracy.
Owner:INST OF ANIMAL HUSBANDRY & VETERINARY FUJIAN ACADEMY OF AGRI SCI

Pelodiscus sinensis picornavirus complete genome sequence and applications thereof

The invention relates to a separated nucleic acid molecule having a nucleotide sequence shown as SEQ ID NO:1 or an antisense sequence of the SEQ ID NO:1. The nucleic acid molecule is derived from pelodiscus sinensis picornavirus strain CNSR2011. The nucleic acid molecule can be used for preparing primers, probes or kits, wherein the primers, the probes and the kits are used for detecting the pelodiscus sinensis picornavirus. The nucleic acid molecule can also be used for preparing a vaccine of the pelodiscus sinensis picornavirus, and an anti-pelodiscus sinensis picornavirus antibody.
Owner:ZHEJIANG INST OF FRESH WATER FISHERIES

Strains, application of strains, vaccine and preparation method of vaccine

InactiveCN105713855AReduce stress responseReduced immunization workloadAntibacterial agentsBacteriaAntigenMink enteritis
The invention relates to the field of biotechnology, in particular to strains, application of the strains, a vaccine and a preparation method of the vaccine, and provides a combined inactivated vaccine for mink parvoviral enteritis and hemorrhagic pneumonia and a preparation process of the combined inactivated vaccine. The (bacterium) virus strains of the vaccine include the mink enteritis parvovirus strain (MEVB strain) and the mink pseudomonas aeruginosa G-type DL15 strain, B-type JL08 strain, C-type WD01 strain, I-type WF05 strain and F-type DL03 strain which are popular in China. The parvoviral enteritis strain and the pseudomonas aeruginosa strains serving as antigens are cultured, inactivated with formaldehyde and then mixed in proportion, aluminium hydroxide colloid is added in proportion, and the vaccine is prepared. The immunity period of the vaccine is 6 months, the immunity protection rate is 80% or above, and the vaccine can be used for preventing mink parvoviral enteritis and mink hemorrhagic pneumonia at the same time, reduces the immunization workload of raising households and the stress response of minks and has good market application prospects.
Owner:INST OF SPECIAL ANIMAL & PLANT SCI OF CAAS

Mink canine parvovirus enteritis pathogen antigen colloidal gold detection test strip and production method thereof

The invention discloses a mink canine parvovirus enteritis pathogen antigen colloidal gold detection test strip and a production method thereof, and relates to the technical field of detection of fur animal viral infectious disease pathogens. The colloidal gold detection test strip comprises a sample pad, a colloidal gold pad, an NC film and an absorption pad, the detection line of the NC film is sprayed with a VP2 protein, and the quality control line of the NC film is sprayed with a goat-anti-mouse second antibody. The production method of the mink canine parvovirus enteritis pathogen antigen colloidal gold detection test strip mainly comprises the following steps: carrying out prokaryotic expression to obtain mink parvovirus (MEV) VP2 and VP1 proteins, and purifying the proteins; preparing an MEV monoclonal antibody; preparing a colloidal gold solution; preparing a colloidal gold antibody solution; preparing the colloidal gold pad; preprocessing the NC film; and assembling. The test strip is helpful for purifying the mink canine parvovirus enteritis in fur animal culturing farms, and is convenient for basic veterinary personnel to operate.
Owner:INST OF SPECIAL ANIMAL & PLANT SCI OF CAAS

Application of diacerein in preparation of antiviral drugs and treatment of virus infection

The invention discloses application of diacerein in preparation of antiviral drugs and treatment of virus infection, and belongs to new application of diacerein. The experimental results prove that diacerein can be used for effectively inhibiting hepatophilic DNA viruses, retroviruses, enteroviruses, orthomyxoviruses, fibroviruses, reoviruses, arenavirus, hepatitis E viruses, astroviruses, circoviruses, coronaviruses, parvoviruses, adenoviruses, polyomaviruses, herpes viruses, poxviruses, human papillomaviruses, paramyxoviruses, flaviviruses, herpes viruses, alphaviruses and rhabdoviruses.
Owner:CHINA INSPECTION SCI PHARM BEIJING GRP CO LTD

Primer, probe and kit for specifically detecting type-3 ungulata bocaviruses parvovirus

The invention discloses a primer, a probe and a kit for specifically detecting type-3 ungulata bocaviruses parvovirus. The detection kit and the detection agent disclosed by the invention have the advantages of detection accuracy, high sensitivity, high specificity, simplicity, convenience and rapidness and is good in detection property.
Owner:中华人民共和国惠州出入境检验检疫局

Fusion protein 210 and its use in optimizing viral replication

The invention provides fusion protein 210 and applications thereof in virus replication optimization. The fusion protein 210 is a truncated part of P60 protein, preserves a function for promoting replication of a plurality of viruses of the P60, and does not generate toxicity on cells in an effective concentration range. The fusion protein 210 can increase the virus titer by two orders of magnitudes in a wide-spectrum range (0.0001-0.1 MOI), and therefore virus identification and detection can be facilitated, rhabdovirus VSV, flaviviridae HCV, parvoviridae EV71, and the like can be detected, and time for detection is shortened by 50% or less. The fusion protein 210 obtained by a prokaryotic expression system is high in expression efficiency and easy to purify, the one-step purification efficiency can be 85% or above, and the protein final concentration can be 3 mg / mL. Accordingly, through directly adding the fusion protein 210 into a virus culture medium, a plurality of virus isolate strains can be detected under low titer conditions, and operation is simple, convenient and rapid. The fusion protein 210 has important influences and significance in the fields of production, learning, researching, and the like of the virology.
Owner:CHINA AGRI UNIV

Fusion protein 210 and applications thereof in virus replication optimization

The invention provides fusion protein 210 and applications thereof in virus replication optimization. The fusion protein 210 is a truncated part of P60 protein, preserves a function for promoting replication of a plurality of viruses of the P60, and does not generate toxicity on cells in an effective concentration range. The fusion protein 210 can increase the virus titer by two orders of magnitudes in a wide-spectrum range (0.0001-0.1 MOI), and therefore virus identification and detection can be facilitated, rhabdovirus VSV, flaviviridae HCV, parvoviridae EV71, and the like can be detected, and time for detection is shortened by 50% or less. The fusion protein 210 obtained by a prokaryotic expression system is high in expression efficiency and easy to purify, the one-step purification efficiency can be 85% or above, and the protein final concentration can be 3 mg / mL. Accordingly, through directly adding the fusion protein 210 into a virus culture medium, a plurality of virus isolate strains can be detected under low titer conditions, and operation is simple, convenient and rapid. The fusion protein 210 has important influences and significance in the fields of production, learning, researching, and the like of the virology.
Owner:CHINA AGRI UNIV

Small RNA (Ribonucleic Acid) virus gene of white foot shrimp and application of small RNA virus gene

The invention discloses a gene of a small RNA (Ribonucleic Acid) virus of white foot shrimps and application of the gene. On the basis of the small RNA virus gene of the white foot shrimp, the nested and fluorescent quantitative PCR detection method of the small RNA virus of the white foot shrimp is established. The established nested PCR method and fluorescent quantitative PCR method are high in sensitivity and good in repeatability and specificity, the lowest detection limit is 10 copies / microliter, and the nested PCR method and the fluorescent quantitative PCR method can be used for screening non-toxic seed shrimps or shrimp seeds and are suitable for being popularized and used in base-level culture units of freshwater shrimps.
Owner:SUN YAT SEN UNIV

Parvoviral vectors and methods of making and use thereof

A recombination parvovirus vector that comprises a parvovirus capsid and a double-stranded vector genome having a sense-strand and an antisense-strand. The sense-strand comprises in the 5' to 3' direction: a parvovirus terminal repeat at the 5' end a coding sequence of a gene of interest (GOI); and a parvovirus terminal repeat at the 3' end. The vector genome further comprises a RNA destabilization / destruction domain (RDDD).
Owner:耐克基因有限责任公司

Human parvovirus: humink parvovirus

Provided herein are sequences of the genomes and encoded proteins of a new human parvovirus, Humink parvovirus, and variants thereof. Also provided are methods of detecting the Humink parvovirus and diagnosing Humink parvovirus infection, methods of treating or preventing Humink parvovirus infection, and methods for identifying anti-Humink parvovirus compounds.
Owner:BLOOD SYST INC

Method for detecting small RNA (Ribonucleic Acid) viruses of freshwater long-arm prawns

The invention discloses a method for detecting small RNA (Ribonucleic Acid) viruses of freshwater long-arm prawns, namely a nested PCR (Polymerase Chain Reaction) and fluorescent quantitative PCR detection method of MrPV-7, which can be used for screening seed prawns or prawn seeds and the like without viruses so as to reduce the loss of the freshwater long-arm prawns in a culture process. The nested PCR and fluorescent quantitative PCR method for detecting the small RNA viruses of the freshwater long-arm prawns, established by the invention, is high in sensitivity and good in specificity and repeatability, and besides qualitative detection of the viruses, the nested PCR and fluorescent quantitative PCR method also can be used for quantitative detection.
Owner:SUN YAT SEN UNIV

Mink parvovirus virus-like particle and its preparation method and application

The mink parvovirus virus-like particle provided by the invention optimizes the mink parvovirus VP2 gene according to the preferred codons of insect cells, and directly combines the 5' end of the optimized VP2 gene with the nucleotide sequence encoding part of the polyhedrin protein Linked, and then cloned into a transfer vector, using the baculovirus / insect cell expression system to produce mink parvovirus virus-like particles. The expression system can be used to produce mink parvovirus virus-like particles safely, efficiently and on a large scale, and the obtained virus-like particles have high titer and good immunogenicity, and both muscle immunity and oral immunization can induce mink body to produce a high level of specificity Antibodies, and can resist the attack of strong venom, provide good protection for mink, and lay the foundation for the preparation of mink viral enteritis vaccine.
Owner:CHANGCHUN SR BIOLOGICAL TECH

Human sepsis pathogen detection kit and detection method

The invention provides a human sepsis pathogen detection kit and a corresponding detection method. The kit provided by the invention comprises primers and fluorescent probes fordetecting acinetobacter baumannii, klebsiella pneumoniae, streptococcus pneumoniae, bacteroides fragilis, staphylococcus aureus, pseudomonas aeruginosa, aeromonas hydrophila, escherichia coli, quail chicken enterococcus, enterobacter cloacae, stenotrophomonas maltophilia, coagulase negative staphylococcus, candida albicans, candida tropicalis, candida glabrata, cytomegalovirus, human herpesvirus type 4, human parvovirus B19, Candida parapsilosis, streptococcus.
Owner:重庆市急救医疗中心重庆市第四人民医院重庆市急救医学研究所 +1

Fluorescent quantitative primer group for visual differential diagnosis of waterfowl parvoviruses

The invention discloses a real-time fluorescent quantitative PCR (Polymerase Chain Reaction) primer group for visual detection on infection conditions of goose parvovirus (GPV) and muscovy duck parvovirus (MDPV) and a method thereof. According to the method, the detection on the infection conditions of GPV and MDPV is carried out by using dissolution curve temperature difference caused by the difference between nucleotide GC contents of GPV and MDPV specific gene fragment regions amplified by primers, and the infection conditions of GPV and MDPV can be subjected to visual differential diagnosis specifically by only combining the SYBR Green I based real-time fluorescent quantitative PCR primer group to dissolution curves which are automatically generated after reaction is ended. The method disclosed by the invention is simple and is relatively high in efficiency and accuracy.
Owner:INST OF ANIMAL HUSBANDRY & VETERINARY FUJIAN ACADEMY OF AGRI SCI

A detection primer and application of tilapia parvovirus tipv CPA

The invention belongs to the field of virus detection, and specifically discloses a detection primer of Tilapia parvovirus (Tilapia parvovirus) TiPV CPA and its application. It is Tilapia parvovirus (Tilapia parvovirus) TiPV, and the preservation number is: CCTCC NO: V201856, which has pioneering significance for the research of Tilapia parvovirus. The primers designed for the virus sequence can detect the tilapia parvovirus, and the primers have good specificity and high sensitivity.
Owner:YANGTZE RIVER FISHERIES RES INST CHINESE ACAD OF FISHERY SCI

LAMP primer for detecting tilapia parvovirus and application thereof

The invention belongs to the field of virus detection, and specifically discloses a LAMP primer for detecting tilapia parvovirus and application thereof, The inventors isolated a parvovirus from the infected tilapia adult fish, which was named tilapia parvovirus (Tilapia parvovirus) TiPV, and its deposit number was CCTCC NO: V201856. It is of pioneering significance for the research of tilapia parvovirus. The primer designed for the specific sequence of the virus can be used to detect tilapia parvovirus. The primer has good specificity and high sensitivity.
Owner:YANGTZE RIVER FISHERIES RES INST CHINESE ACAD OF FISHERY SCI

Treatment of cancer harboring mutations in the tp53 gene and/or post-translational modifications in the p53 protein with parvoviruses

PendingCN113677370AP53 proteinUnknown materialsGenes mutationProtoparvovirus
Treatment of cancer harboring mutations in the TP53 gene and / or post-translational modifications in the p53 protein. The present invention relates to the use of viruses belonging to the family Parvoviridae, genus Protoparvovirus, or combinations of such viruses with chemotherapy drugs, in the treatment of cancer. In particular the cancer is characterized by showing mutations in the TP53 gene and / or post-translational modifications in the p53 protein.
Owner:AUTONOMOUS UNIVERSITY OF MADRID

TiPV and PCR detection primer for tilapia parvovirus and application

The invention belongs to the field of virus detection, and specifically discloses a TiPV and PCR detection primer for tilapia parvovirus and application. The inventors isolated a parvovirus from the infected tilapia adult fish, which was named tilapia parvovirus (Tilapia parvovirus) TiPV, and its deposit number was CCTCC NO: V201856. It is of pioneering significance for the research of tilapia parvovirus. The primer designed for the specific sequence of the virus can be used to detect tilapia parvovirus. The primer has good specificity and high sensitivity.
Owner:YANGTZE RIVER FISHERIES RES INST CHINESE ACAD OF FISHERY SCI

A kind of tilapia parvovirus tipv and pcr detection primer and its application

The invention belongs to the field of virus detection, and specifically discloses a TiPV and PCR detection primer for tilapia parvovirus and application. The inventors isolated a parvovirus from the infected tilapia adult fish, which was named tilapia parvovirus (Tilapia parvovirus) TiPV, and its deposit number was CCTCC NO: V201856. It is of pioneering significance for the research of tilapia parvovirus. The primer designed for the specific sequence of the virus can be used to detect tilapia parvovirus. The primer has good specificity and high sensitivity.
Owner:YANGTZE RIVER FISHERIES RES INST CHINESE ACAD OF FISHERY SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products